PTC Therapeutics, Inc. (PTCT)
71.47
-1.25
(-1.72%)
USD |
NASDAQ |
May 15, 16:00
71.41
-0.06
(-0.08%)
After-Hours: 20:00
PTC Therapeutics Profit Margin (Quarterly) : -1.03% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 45.29% |
| Keros Therapeutics, Inc. | -6.46K% |
| Insmed, Inc. | -53.46% |
| Madrigal Pharmaceuticals, Inc. | -30.32% |
| Protagonist Therapeutics, Inc. | 6.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -6.81% |
| Return on Invested Capital | -89.10% |
| Gross Profit Margin (Quarterly) | 85.47% |
| Operating Margin (Quarterly) | 16.84% |
| Return on Net Operating Assets | -24.54% |